Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial

Autor: Hamada, Hiromichi, Honda, Takafumi, Yasukawa, Kumi, Hirai, Katsuki, Takahiro, Nishihara, Soga, Takashi, Yajima, Hideoki, Ooto, Hideyasu, Umeda, You, Suzuki, Hiroyuki, Takeuchi, Takashi, Suenaga, Tomohiro, Kakimoto, Nobuyuki, Ishiguchi, Yukiko, Kamada, Masahiro, Okuma, Yoshiaki, Takada, Nobuyuki, Suwabe, Shinichi, Yanai, Masaaki, Ueno, Yasushi, Nishi, Natsuko, Sato, Junichi, Saito, Yuuko, Kitani, Yutaka, Nakayashiro, Mami, Nabeshima, Taisuke, Takefuta, Kiyotaka, Ayusawa, Mamoru, Nakamura, Takahiro, Komori, Akiko, Kato, Masataka, Ebata, Ryota, Saito, Naoki, Okunushi, Kentaro, Kobayashi, Hironobu, Yamamoto, Eiichi, Nakano, Takeshi, Nomura, Yuichi, Masuda, Kiminori, Hashimura, Yuya, Minami, Hirotaka, Uchiyama, Takamichi, Okizuka, You, Ouchi, Kazunobu, Ohno, Naoki, Ogita, Satoko, Masuda, Hiroshi, Ono, Hiroshi, Ishiguro, Akira, Takatsuki, Shinichi, Saji, Tsutomu, Ichida, Fukiko, Hirono, Keiichi, Ozawa, Sayaka, Ariga, Tadashi, Takeda, Atsuhito, Izumi, Gaku, Higaki, Takashi, Otsuki, Akio, Hata, Akira, Hanaoka, Hideki, Terai, Masaru, Onouchi, Yoshihiro, Terauchi, Moe, Fujii, Yasuhisa, Sato, Takatoshi, Aoyagi, Reiko, Hanawa, Michiko, Fujiwara, Tadami, Fuse, Shigeto, Okajima, Yoshitomo, Kurotobi, Shunji

Publikováno v: In The Lancet 16-22 March 2019 393(10176):1128-1137